medline.ch Neurologie Alzheimer

	Plasma p-tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach. Alzheimers Dement (Amst) Brodini G, Roveta F, Chiarandon AM, Boschi S, Bonino L, Piella EM, Cermelli A, Limoncelli S, Gioiello G, Zotta M, Lesca A, Mengozzi G, Morbelli S, Rainero I, Rubino E. PMID: 41756817 [PubMed - in process]
	The 2024 NIA-AA biological definition of Alzheimer's disease: linking biomarkers to clinical practice. Front Dement Kobayashi G, Hirata K, Ono M, Kasuga K, Takado Y. PMID: 41756762 [PubMed - in process]
	Serum amino acid levels are associated with brain hypometabolism in patients across the Alzheimer's disease continuum. IBRO Neurosci Rep Nasiri H, Nemati R, Orangi K, Mansouri M, Saranjam A, Esmizadeh F, Sadeghi M, Sattari K, Salem H, Mayeli M, Sadi S, Alzheimer's Disease Neuroimaging Initiative. PMID: 41756407 [PubMed - in process]
	Matching heterogeneous cohorts by projected principal components reveals two novel Alzheimer's disease-associated genes in the Hispanic population. Alzheimers Dement Willett JDS, Waqas M, Naumenko S, Mullin K, Hecker J, Bertram L, Lange C, Vlachos I, Hide W, Tanzi RE, Prokopenko D. PMID: 41755704 [PubMed - in process]
	Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility. Alzheimers Dement Milà-Alomà M, Hausle I, Myoraku A, Sorensen C, Thropp P, Shaw LM, Weiner MW, Tosun D, Alzheimer's Disease Neuroimaging Initiative. PMID: 41755682 [PubMed - in process]
	Alzheimer's disease and dementia care in Nigeria: Challenges, realities, and the call for a national strategy. J Alzheimers Dis Ndionuka IB. PMID: 41755465 [PubMed - as supplied by publisher]
	Recent Advances in Nanoparticle-Based Drug Delivery Strategies to Cross the Blood-Brain Barrier in Targeted Treatment of Alzheimer's Disease. Pharmaceutics Le H, Vu GTT, Abioye A, Adejare A. PMID: 41754934 [PubMed - in process]
	The Potential Use of Matrix Metalloproteinases in Alzheimer's Disease Therapy. J Clin Med Krawczuk D, Mroczko B. PMID: 41753242 [PubMed - in process]
	Taurine as an Early-Phase Disease-Modifying Candidate for Alzheimer's Disease. Int J Mol Sci Hossain MK, Kim HR. PMID: 41752008 [PubMed - in process]
	Role of the Clock Drawing Test in Differential Diagnosis of Alzheimer's Disease: Clinical Findings in Relation to CSF Biomarkers. Int J Mol Sci Cermelli A, Lombardo C, Chiarandon AM, Roveta F, Piella EM, Batti V, Rubino E, Rainero I, Boschi S. PMID: 41751927 [PubMed - in process]
	Multi-Entropy Feature Concatenation for Data-Efficient Cross-Subject Classification of Alzheimer's Disease and Frontotemporal Dementia from Single-Channel EEG. Entropy (Basel) Li J, Ling C, Zhang W, Lv J, Hu X, Lin K, Yuan J, Zhang S, Chen R. PMID: 41751714 [PubMed]
	Alzheimer's 2030: From Precision Genomics to Artificial Intelligence. Genes (Basel) D'Argenio V, Tomaiuolo R, Bargeri S, Sancesario G. PMID: 41751617 [PubMed - in process]
	New SPRi Biosensors for Simultaneous Detection of Tau Protein Isoforms-The Importance of the Ptau181/Total Tau Ratio in Alzheimer's Disease. Biomedicines Zielinska Z, Gorodkiewicz E. PMID: 41751250 [PubMed - in process]
	Dynamic Mode Decomposition-Based Clustered Pattern Projection for Reliable Alzheimer's Disease Detection from EEG. Diagnostics (Basel) Seo JH, Kang H, Kang J, Zreikat AI. PMID: 41750680 [PubMed]
	Association of Human Gut Microbiota with Alzheimer's Disease Pathogenesis: An Exploratory Clinical Study. Brain Sci Ohara T, Taki Y. PMID: 41750242 [PubMed - in process]
	Interpretable Network-Level Biomarker Discovery for Alzheimer's Stage Assessment Using Resting-State fNIRS Complexity Graphs. Brain Sci Kang MK, Elisabet A, Yoo SH, Hong KS. PMID: 41750239 [PubMed]
	Neuroimmune Interactions in Neurodegeneration: The Role of Microglia in Alzheimer's and Parkinson's Disease Pathogenesis. Brain Sci Goyal P, Baldaniya L, Tyagi LK, Joshi KK, Ballal S, Sabarivani A, Ray S, Nathiya D, Chauhan AS, Gulati M, Behl T, Akhtar A. PMID: 41750155 [PubMed - in process]
	Predicting Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using a Vision Transformer and Hippocampal MRI Slices. Bioengineering (Basel) Seiger R, Fierlinger P, Alzheimer. PMID: 41749703 [PubMed]
	Phase II clinical trial of KCHO-1 for Alzheimer's disease: study protocol for a multicenter, randomized, double-blind, multi-dose, placebo trial. Trials Shin J, Jeong TS, Jung HS, Kim D, Kim CH, Yi S, Kang HW, Han D, Kim S. PMID: 41749280 [PubMed - as supplied by publisher]
	Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's disease - Mechanisms and therapeutic frontiers. Mol Cell Neurosci Waghmare A, Rahangadale S, Khare K, Taksande B, Umekar M, Mangrulkar S. PMID: 41747877 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 69244

Seite 1 von 3463

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung